Please assess the completion status of the following clinical trial:

Trial Title: PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Liver tumor diagnosed histologically as HCC or suspected of being HCC in association with serum alpha-fetoprotein level \> 200 or tumor mass with characteristics of malignancy on diagnostic imaging~* Under the care of a surgical attending~* Deemed a surgical candidate and has agreed to surgery to remove a portion of the liver containing tumor~* Child-Pugh A/B~Exclusion Criteria:~* Weight \> 350 lbs~* Pregnant or lactating female, a serum pregnancy test will be performed within 2 weeks or less before the date of the FCH PET/CT scan in all women capable of becoming pregnant~* Serious underlying medical condition that would impair patient's ability to tolerate the imaging procedure~* Concurrent treatment with chemotherapy, molecule-selective, biological, or radiotherapeutic agent

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 18F-fluoromethylcholine PET/CT (Type: EXPERIMENTAL): Patients undergo 18F-fluoromethylcholine positron emission tomography (PET)/ computed tomography (CT) scan within 14 days of surgical resection of liver tumor.

Based on this trial design, predict the completion outcome and termination type (if applicable).